nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Multiple drugs

Drug-induced liver injury: 53 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

FDC combination with sulbactam was not stated in the article. However, the ADR was attributed to sulbactam; therefore, it was considered as a suspect drug.

Shen T, et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology 156: 2230-2241, No. 8, Jun 2019. Available from: URL: http://doi.org/10.1053/j.gastro.2019.02.002 - China

Titel: Multiple drugs
Drug-induced liver injury: 53 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63786-y

Atropine/lacosamide/norepinephrine

Case report

Dextromethorphan/diphenhydramine abuse

Case report

Adalimumab

Case report

Dalbavancin off-label use

Case report

Tenofovir-disoproxil-fumarate

Case report

Olanzapine

Case report

Springer Medizin

Multiple drugs

Drug-induced liver injury: 53 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Atropine/lacosamide/norepinephrine

Dextromethorphan/diphenhydramine abuse

Adalimumab

Dalbavancin off-label use

Tenofovir-disoproxil-fumarate

Olanzapine

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Atropine/lacosamide/norepinephrine

Dextromethorphan/diphenhydramine abuse

Adalimumab

Dalbavancin off-label use

Tenofovir-disoproxil-fumarate

Olanzapine